Clinical Trial Update: Use of the PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction [NA]

View source ↗

Summary

A clinical trial evaluating the PEAK PlasmaBlade 4.0 for bilateral breast reduction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macromastia

Snippet

Sponsor: Medtronic Surgical Technologies | Conditions: Macromastia (Symptomatic) | NA | Status: WITHDRAWN